Cited by 303Retinal Development and DisordersRetinal Diseases and TreatmentsAutophagy in Disease and Therapy

The DOI matches its Crossref record; 89 of the 90 references it cites were found in a registry or an index, and 1 are not checked yet.

mTOR-mediated dedifferentiation of the retinal pigment epithelium initiates photoreceptor degeneration in mice

Open access

Abstract

Retinal pigment epithelial (RPE) cell dysfunction plays a central role in various retinal degenerative diseases, but knowledge is limited regarding the pathways responsible for adult RPE stress responses in vivo. RPE mitochondrial dysfunction has been implicated in the pathogenesis of several forms of retinal degeneration. Here we have shown that postnatal ablation of RPE mitochondrial oxidative phosphorylation in mice triggers gradual epithelium dedifferentiation, typified by reduction of RPE-characteristic proteins and cellular hypertrophy. The electrical response of the retina to light decreased and photoreceptors eventually degenerated. Abnormal RPE cell behavior was associated with increased glycolysis and activation of, and dependence upon, the hepatocyte growth factor/met proto-oncogene pathway. RPE dedifferentiation and hypertrophy arose through stimulation of the AKT/mammalian target of rapamycin (AKT/mTOR) pathway. Administration of an oxidant to wild-type mice also caused RPE dedifferentiation and mTOR activation. Importantly, treatment with the mTOR inhibitor rapamycin blunted key aspects of dedifferentiation and preserved photoreceptor function for both insults. These results reveal an in vivo response of the mature RPE to diverse stressors that prolongs RPE cell survival at the expense of epithelial attributes and photoreceptor function. Our findings provide a rationale for mTOR pathway inhibition as a therapeutic strategy for retinal degenerative diseases involving RPE stress.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci44303

Cites

89 of 90 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 89 references

Research works printed but not linked: 10

  1. Exp Eye Res.
  2. Eagle, 1982, Trans Am Ophthalmol Soc., 80, 218
  3. Miceli, 1990, Invest Ophthalmol Vis Sci., 31, 277
  4. Glocklin, 1965, Invest Ophthalmol., 4, 226
  5. Lacovelli, Invest Ophthalmol Vis Sci.
  6. Mishima, 1999, Invest Ophthalmol Vis Sci., 40, 1590
  7. 10.1042/0264-6021:3440427 · DOI
  8. Liu, 2010, Mol Vis., 16, 184
  9. Carracedo, 2008, J Clin Invest., 118, 3065
  10. Kinkade, 2008, J Clin Invest., 118, 3051

Cited by

Sorted by citations

Metadata

Authors
Zhao, C., Yasumura, D., Li, X., Matthes, M., Lloyd, M., Nielsen, G., Ahern, K., Snyder, M., Bok, D., Dunaief, J. L., LaVail, M. M., & Vollrath, D.
Affiliations
  • Stanford Medicine (US)
  • University of California, San Francisco (US)
  • University of California, Los Angeles (US)
  • University of Pennsylvania (US)
Corresponding author
Vollrath, Douglas
Venue
Journal of Clinical Investigation
Published
2011-01-04
Volume
121
Issue
1
Pages
369-383
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2002712265
Cited by
303
References
89
Citations by year
2026: 10 · 2025: 11 · 2024: 25 · 2023: 27 · 2022: 31 · 2021: 26 · 2020: 35 · 2019: 16 · 2018: 11 · 2017: 20 · 2016: 16 · 2015: 18 · 2014: 23 · 2013: 15 · 2012: 10
FWCI
4.43
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Research to Prevent Blindness (EY00331, P30EY002162)
  • Edward N. and Della L. Thome Memorial Foundation
  • National Institutes of Health (EY 00331, EY001919)
  • National Eye Institute (EY 015240, P30EY002162, R01EY001919, EY-00331, R03EY014650, R01EY006842, EY001919, R01EY015240, P30EY000331, EY014650)
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
Keywords
retinal pigment epithelium, photoreceptor degeneration, mTOR signaling, Akt/mTOR signaling, glycolysis, hepatocyte growth factor, MET oncogene, rapamycin, retinal degeneration
MeSH terms
Animals, Autophagy, Cell Movement, Cell Survival, Female, Glycolysis, Hypertrophy, Male, Mice, Transgenic, Oxidative Phosphorylation, Retinal Degeneration, Signal Transduction, Cell Death, Hepatocyte Growth Factor, Proto-Oncogene Proteins c-met, Sirolimus, Photoreceptor Cells, Vertebrate, Proto-Oncogene Proteins c-akt, Mice, Cell Dedifferentiation, Retinal Pigment Epithelium, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review